Cellid stock price
셀리드KRX:299660 · KOSDAQ · HealthcareToday's signals · No active technical signal.
Signal details →Cellid last closed at ₩2,450 (+1.66%) on 2026-10-02. Listed on KOSDAQ. Trailing 12 months PER is -2.6×. Its overall grade ranks 280 of 306 stocks in Healthcare.
About this company
Cellid last closed at ₩2,450 (+1.66%) on 2026-10-02. Listed on KOSDAQ.
Details →Reported results
Position in sector
Healthcare · Overall F · 280/306
Valuation grade B-
Recent filings
DART · received recent list, not a complete filing history. Factual information, not investment advice.
Related stocks
- 한미약품Competitor
항암·면역치료제 등 바이오 신약 개발 경쟁사
- 유한양행Competitor
국내 신약개발·기술수출 경쟁사
- 제넥신Competitor
면역항암제·세포/유전자 치료제 개발 경쟁사
About Cellid
- What technical signals does Cellid (299660) have?
- Cellid current technical signals: no active technical signal.
- Is Cellid a cup-and-handle pattern?
- No. Cellid has no valid Cup signal right now.
- What published figures are available for Cellid?
- Market cap: KRW 72.28B. Trailing 12 months PER: -2.6×. Latest quarter PBR: 1.34×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Cellid, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).